HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Intravitreal implants: drug carriers and carriers of hope?].

Abstract
Immunosuppressive agents are used for the therapy of noninfectious uveitis if intraocular quiescence and freedom from recurrences are not achievable with oral steroids at a low dosage. Partially, severe side effects are tolerated to preserve visual acuity even if the disease is limited to the eyes. Because of this a therapy would be desirable which is highly effective, limited to the eyes and with few side effects. For this fluocinolone acetonide and dexamethasone drug delivery systems were developed. Dexamethasone implants were already approved for the therapy of retinal vein occlusions and are used successfully. Diabetic macular edema would be another possible indication for dexamethasone implants.
AuthorsS Winterhalter, P Ruokonen, K H van der Velden, U Pleyer, A M Joussen
JournalDer Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft (Ophthalmologe) Vol. 108 Issue 3 Pg. 222-9 (Mar 2011) ISSN: 1433-0423 [Electronic] Germany
Vernacular TitleIntravitreale Implantate: Wirkstoff- und "Hoffnungsträger"?
PMID21424918 (Publication Type: Comparative Study, English Abstract, Journal Article, Review)
Chemical References
  • Adrenal Cortex Hormones
  • Drug Carriers
  • Drug Implants
  • Immunosuppressive Agents
  • Fluocinolone Acetonide
  • Dexamethasone
Topics
  • Adrenal Cortex Hormones (administration & dosage, adverse effects)
  • Chronic Disease
  • Dexamethasone (administration & dosage, adverse effects)
  • Diabetic Retinopathy (drug therapy, immunology)
  • Drug Carriers
  • Drug Implants
  • Drug Resistance
  • Fluocinolone Acetonide (administration & dosage, adverse effects)
  • Humans
  • Immunosuppressive Agents (administration & dosage, adverse effects)
  • Macular Edema (drug therapy, immunology)
  • Randomized Controlled Trials as Topic
  • Retinal Vein Occlusion (drug therapy, immunology)
  • Secondary Prevention
  • Uveitis, Intermediate (drug therapy, immunology)
  • Uveitis, Posterior (drug therapy, immunology)
  • Visual Acuity (drug effects)
  • Vitreous Body (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: